Of all liver laboratory and imaging markers, only AST and albumin were significantly higher in the ALD cohort vs the NAFLD cohort (53.5 IU/L vs 35.0 IU/L and 4.6 g/L vs 4.4 g/L, respectively) (Table 1). This evidence concerns the gene ALB and metabolic dysfunction-associated steatotic liver disease.